Aggression

Overview

4.6 out of 5 (163 Reviews)

Credits

1.50

Post Assessment Questions

10

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Aggression has been treated by both medications and psychotherapy, but relapses are common. Aggressive patients frequently run into legal problems because of their behavior. This activity reviews the evaluation and management of aggression and highlights the role of the interprofessional team in the recognition and management of aggression.

UAN: JA4008338-0000-23-303-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, nurse practitioners, and social workers.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Review the pathophysiologic basis of aggression.
  • Outline the expected history and physical findings for a patient with aggression.
  • Explain the treatment options available for aggression.
  • Summarize the interprofessional team strategies for improving care coordination and communication for patients with aggression.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.50 ACPE credit(s). (UAN: JA4008338-0000-23-303-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

cvzvzv

Richard P. on 2/26/2021

Melanie S. on 3/19/2021

Julie J. on 4/5/2021

Raul M. on 4/10/2021

Bernadette S. on 4/19/2021

Discuss use of Alpha-2 Agonists in treating aggression (clonidine, guanfacine.)

Henry H. on 7/11/2021

Caleb P. on 7/28/2021

Rebecca B. on 9/1/2021

David G. on 9/23/2021

Kelli H. on 9/13/2021

Sonia S. on 9/14/2021

Derek K. on 9/19/2021

Michael P. on 9/25/2021

MIA G. on 10/14/2021

Jennifer S. on 10/23/2021

Joseph on 11/11/2021

Diane P. on 11/30/2021

Charlene N. on 12/1/2021

NONE AT THIS TIME

Okechukwu O. on 12/11/2021

Jeffrey H. on 12/18/2021

Kelly S. on 12/28/2021

Sina L. on 1/16/2022

Melinda N. on 1/18/2022

Jessica B. on 1/23/2022

Emma P. on 1/24/2022

Gwendolyn R. on 1/26/2022

elizabeth d. on 1/27/2022

Heesoon G. on 1/29/2022

Candace B. on 1/31/2022

Samantha B. on 2/4/2022

Charlene N. on 2/24/2022

Cynthia F. on 2/27/2022

Deborah V. on 3/10/2022

Ira on 3/17/2022

Ryan E. on 3/23/2022

Ronda G. on 4/10/2022

Christopher N. on 4/26/2022

Jacklyn V. on 4/22/2022

Harry C. on 5/8/2022

Lauren I. on 5/31/2022

Thomas J. on 6/19/2022

Paul M. on 6/27/2022

Robin J. on 6/27/2022

loretta p. on 7/5/2022

Jessica K. on 12/26/2022

Charles T. on 7/24/2022

Megan S. on 8/16/2022

Brian K. on 7/31/2022

Devan C. on 12/7/2022

Tammy L. on 8/16/2022

Peter M. on 8/17/2022

Michael S. on 9/6/2022

Melanie D. on 9/11/2022

W Lawrence D. on 9/28/2022

April D. on 10/5/2022

Jeannine D. on 10/30/2022

Oula C. on 10/31/2022

Sarah P. on 11/14/2022

Cecelia N. on 11/25/2022

Amy l. on 11/28/2022

Heather K. on 12/4/2022

Marlena B. on 12/23/2022

Andrew M. on 12/24/2022

Adriana S. on 12/28/2022

Bergen S. on 12/30/2022

Latoya R. on 1/21/2023

Significant editing indicated.

Samantha L. on 1/31/2023

Jennifer A. on 2/3/2023

Emmanuel E. on 2/11/2023

Sharon M. on 2/11/2023

Jeannine D. on 2/16/2023

Stephanie D. on 2/21/2023

Charles H. on 3/12/2023

none

Ritu R. on 4/4/2023

Arun K. on 4/6/2023

Kelcy C. on 4/10/2023

Susan M. on 4/13/2023

Adithya nikhileshwar B. on 4/23/2023

coral c. on 4/26/2023

Pamela D. on 4/29/2023

Nida A. on 5/8/2023

Gregory P. on 5/5/2023

Christina C. on 5/15/2023

Michael P. on 5/23/2023

Scott S. on 5/26/2023

Peter M. on 6/1/2023

Cheryl M. on 6/8/2023

Richard K. on 6/28/2023

Rebecca L. on 7/11/2023

larry I. on 7/16/2023

John P. on 8/11/2023

Hansika S. on 8/4/2023

shayna m. on 8/8/2023

Wayne S. on 8/11/2023

Laura M. on 8/19/2023

Parash Pratim B. on 8/22/2023

Shilpa T. on 9/3/2023

Lynzee B. on 9/11/2023

Nivetha V. on 9/16/2023

Lynne W. on 9/21/2023

Jean V. on 9/27/2023

Lindsie C. on 10/26/2023

John M. on 10/12/2023

Angie L. on 10/20/2023

Devyani S. on 10/26/2023

John T. on 10/31/2023

Beji J. on 11/2/2023

Lazo K. on 11/3/2023

Gordon C. on 11/16/2023

Joseph k. on 11/20/2023

Hung N. on 11/25/2023

Sailatha B. on 11/26/2023

Sushma B. on 11/27/2023

Drew M. on 11/28/2023

Nanette M. on 12/1/2023

Malani K. on 12/3/2023

MICHELLE B. on 12/4/2023

Mohamed E. on 12/6/2023

Wojciech F. on 12/13/2023

Andrew f. on 12/17/2023

Dr. Neha K. on 12/22/2023

Alexei K. on 12/22/2023

sikhumbuzo m. on 12/23/2023

Herman E. on 12/24/2023

Joy P. on 12/25/2023

Danielle K. on 12/26/2023

Brian M. on 12/26/2023

Jeffrey H. on 12/27/2023

Stacy c. on 12/27/2023

Susan M. on 12/27/2023

osei b. on 12/31/2023

Jyotsna r. on 12/31/2023

Dr. Amer J. on 12/31/2023

John P. on 1/5/2024

Anne C. on 1/13/2024

Michael P. on 1/14/2024

Michelle C. on 1/15/2024

Justin C. on 1/16/2024

Joseph S. on 1/18/2024

Alex M. on 1/18/2024

Jayakaviyah R. on 2/4/2024

Shiela R. on 1/22/2024

MOHAMMAD R. on 1/23/2024

Bhabesh D. on 1/27/2024

brian w. on 2/4/2024

Tarun S. on 2/5/2024

Stacy c. on 2/5/2024

Jibril Y. on 2/18/2024

Elizabeth H. on 2/26/2024

Enitan E. on 2/26/2024

Nicole C. on 2/29/2024

Julie J. on 3/5/2024

Karen L. on 3/7/2024

daniel h. on 3/16/2024

Boris S. on 3/30/2024

Lindsey A. on 4/5/2024

Fernando M. on 4/7/2024

Kaman C. on 4/12/2024

larry m. on 4/11/2024

Jessica C. on 4/11/2024

thomas d. on 4/15/2024

Gretchen M. on 4/16/2024

Karen M. on 4/17/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6673 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7924.5 hours of CE.

Single Activity

Take this single activity

$43.50 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$199 per 1 year per user